Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes

por Pecorelli, S., Ray-Coquard, I., Tredan, O., Colombo, N., Parma, G., Tisi, G., Katsaròs, D., Lhommé, C., Lissoni, A. A., Vermorken, J. B., du Bois, A., Poveda, A., Frigerio, L., Barbieri, P., Carminati, P., Brienza, S., Guastalla, J. P.
Publicado 2010

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

por Lee, C K, Simes, R J, Brown, C, Lord, S, Wagner, U, Plante, M, Vergote, I, Pisano, C, Parma, G, Burges, A, Bourgeois, H, Högberg, T, Bentley, J, Angleitner-Boubenizek, L, Ferrero, A, Richter, B, Hirte, H, Gebski, V, Pfisterer, J, Pujade-Lauraine, E, Friedlander, M
Publicado 2011